chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This 43 year old reported receipt of 6 Anthrax vaccinations between 1999 and 2004. He remembers typically experienced adverse events to include malaise, flu-like syndrome and fevers for one week. Onset cough, sob, calf pain, swelling Jan-March 2007 with dx Pulm embolism and DVT: common and superficial veins of leg. 7/13/07-records received-12/06 began to experience right calf pains, 1/07-experienced shortness of breath with wheezing. DX bronchitis.  3/07 right calf pain and calf swollen from knee to foot, US revealed blood clot. DVT. Treated with anticoagulant therapy. Surgery and TPA to remove clot. Right basal segmental pulmonary emboli.
Tingling at tongue, cheeks and lips; Numbness at tongue, cheeks and lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling at tongue, cheeks and lips) and HYPOAESTHESIA (Numbness at tongue, cheeks and lips) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011D21A and 037C21A) for COVID-19 vaccination.    No Medical History information was reported.   On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jul-2021, the patient experienced PARAESTHESIA (Tingling at tongue, cheeks and lips) and HYPOAESTHESIA (Numbness at tongue, cheeks and lips). At the time of the report, PARAESTHESIA (Tingling at tongue, cheeks and lips) and HYPOAESTHESIA (Numbness at tongue, cheeks and lips) had not resolved.            No relevant concomitant medications were reported. Patient did not receive any treatment.   This case was linked to MOD-2021-405932 (Patient Link).
A few weeks after the first SHINGRIX vaccine patient developed a sensory level from bra line down to feet which led to gait instability and numbness. This was similar to the 2000 episode of transverse myelitis in that it was the exact same sensory level, but symptoms were more severe this time, and recovery this time has been prolonged and is still ongoing. My best impression as the treating neurologist is that she has multiple sclerosis based on the 2000 episode of tranverse myelitis, a 2015 episode of electric shocks down left leg, and the MRI appearance of multiple short segment cord lesions with brainstem and one periventricular lesion. None of the lesions were enhancing. She received steroids the end of May with some relief, but otherwise is still improving in regard to sensory loss and gait instability.
Initial report received from a health care professional on 09 Dec 2009: This patient inadvertently received S-OIV FLUVIRIN 0.5 ml intramuscular, on 05 Dec 2009. No adverse events were reported upon administration. Following an internal review on 11 Feb 2010 of the data received on 09 Dec 2009 following changes was made: The event off label use was coded.
Severe weakness, fever, headache, nausea, vomiting, diarrhea,
approx 35min p/vax pt c/o numbness & tingling to rt side of face, back, shoulder, & arm;
tingling sensation on all of the right side of my body; pinky finger got twitched; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation on all of the right side of my body) and MUSCLE TWITCHING (pinky finger got twitched) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PARAESTHESIA (tingling sensation on all of the right side of my body) and MUSCLE TWITCHING (pinky finger got twitched). At the time of the report, PARAESTHESIA (tingling sensation on all of the right side of my body) and MUSCLE TWITCHING (pinky finger got twitched) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment medications were not provided by the reporter.    This case was linked to MOD-2021-127292 (Patient Link).
nonstop suicidal thoughts; Extreme anxiety; This is a spontaneous report from a contactable consumer. A 46-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 20Aug2021 (Batch/Lot Number: fc3182) as DOSE 2, SINGLE (at the age of 46 years) for covid-19 immunisation. Relevant medical history included crohn's disease from an unknown date and unknown if ongoing, lactose intolerant from an unknown date and unknown if ongoing (known allergies: lactose intolerant). The patient's concomitant medications were not reported. The patient received the first dose of BNT162B2 on 30Jul2021 (lot number: ew0198) in the left arm at the age of 46 years for Covid-19 immunisation. In Aug2021, the patient had non-stop suicidal thoughts and extreme anxiety. The patient did not receive treatment for the event. The patient underwent lab tests and procedures which included sars-cov-2 test via nasal swab negative on 23Sep2021. The outcome of the events was not recovered at the time of the report.   Follow-up attempts are completed. No further information is expected. Information about batch/lot number already obtained.
pt had a positive COVID test on 1/24/22; brought by EMS to ED on 2/2/22 with c/o increasing SOB and generalized weakness; EMS placed NRB on pt and gave a breathing tx; in ED found to have COVID pneumonia; poor oral intake cough; O2 supplementation given; ABX given; DNR; pt refuses blood transfusions and platelets; desires to go home; dc'd to home with home health care scheduled (no mention of the name of home health in med records); pt passed  away at home; death certificate and med records sent to info@vaers.org per VAERS request
Adverse events: Nausea - mild at time of vaccine and exacerbated late evening 12/07/17 persisting till time seen at Urgent Care; rash/hives seen morning of 12/08/17; wheezing found by doctor when seen 1:30 pm 12/08/17. Treatment: ZOFRAN at the Center for nausea; BENADRYL shot for hives/rash; prescription for Prednisone 20 for wheeze and above-reported symptoms. Outcome.
Patient here with mother for 2nd dose primary pfizer vaccine. Checked "Covid Vaccine Schedule" handout provided by facility to staff, rev 10.13.2022. Schedule stated "2nd dose primary," Note in dot with no mention on Monovalent vs. Bivalent.  Given pfizer covid 19 vaccine bilvalent 0.2ml IM on RVL. tolerated well. No adverse reactions noted at the time of administration. In the afternoon nurse was given updated "covid-19 vaccine schedule" handout, dated 12/12/2022. Noted on updated schedule stating "2nd dose Monovalent." Supervisor notified. Chart cc'ed to md for review.
During the night after the vaccine, I started experiencing bladder incontinence. It happened again the next night, so I started wearing disposable underwear at night. The incontinence went away about the middle of March 2023. I don't know if this was a result of the booster, but the timing was unusual.  I had never experienced this before, so thought I should report it. Thank you.
While in observation, patient reported feeling nauseous and was mildly diaphoretic. Vilas taken, 95/58 bp at the time. Patient then began to complain of chest pain. Vital signs taken again, as vital signs were being taken, pt reported relief from both nausea and chest pain. pt observation extended to 30 minutes. @ more vitals completed, all within normal limits. Pt refused further evaluation by md. Patient left facility with no complaints and a steady gait.
Redness, swelling and pain below injection site on left arm presented 48 hours after administration.
This spontaneous report as received from a registered nurse refers to a 65-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 21-FEB-2017, the patient was vaccinated with an improperly stored dose of PNEUMOVAX23 injection (intramuscularly, lot # L040178 with expiration date 18-AUG-2017; dose was not reported). The vaccine was exposed to the temperature between 8 and 25 degrees Celsius for 26 hours. Previous temperature excursions included the temperature between 8 and 25 degrees Celsius for 14 hours 10 minutes and the temperature between 0 and 2 degrees Celsius for 24 hours. Digital data logger was involved. No adverse effects were reported. This is one of several reports from the same reporter. No additional information is available. Additional information is not expected as all scheduled correspondence has been received.; Sender's Comments: US-009507513-1703USA012482: US-009507513-1701USA014175:
On 02/05/2001 at titer was drawn that showed that the patient had failed to seroconvert. It was reported that there were no side effects. The patient does not want a third dose. No further information is available.
but in between we caught the virus; but in between we caught the virus; We never got the second one; This is a spontaneous report received from a non-contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on Jan2021 as single dose for covid-19 immunization. The patient medical history and concomitant medication were not reported. Caller stated as I'm calling for me and my wife we both had first dose of the Pfizer-COVID-19 Vaccine in January, we would do a try to get the second one 3 weeks later, but in between we caught the virus, we were treated for the virus and we tested negative the last time we had a test. We never got the second one (second dose of the vaccine). The patient underwent lab tests and procedures which included sars-cov-2 test and tested negative last time. Outcome for COVID-19 was recovered on an unspecified date and remaining events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021314187 same reporter/drug/event different patient
Pt recieved 5th Anthrax shot on 1MAy04 and on 3May04 begain experiencing multiple joint pain to shoulders, elbows, knee, ankles and hips.  Currently is still having L elbow joint pain, not as severe, but is limiting job capabilities
7 days after 1st shot, I started getting an intense neck pain on right side of neck. This pain continued for next three days, only subsiding when I slept at night. Then the pain traveled up base of my skull and I?ve had intense headaches for the last 5 days. It comes and goes throughout the day. No OTC meds seem to work. Definitely not the normal headache pain I might get once in awhile.
pain at injection site, weakness and achiness in left arm where injection was administered. symptoms began 1 hour after injection administration. treated with ibuprofen and warm soaks.
Information has been received from a physician concerning a 19 year old female who on 08-APR-2008 was vaccinated with her second dose of GARDASIL (lot# not provided).  On 10-APR-2008 the patient experienced a rash at the injection site, rash on her chest and rash on her abdomen.  The rash was a scaly red rash with vesicles.  The patient feels well and was afebrile.  The patient was being seen at the urgent care center.  The patient's rash at the injection site and rash on her chest and rash on her abdomen persisted.  No further information is available.
Started with flu like Symptoms. Fever fatigue and sick for first week. Also had swollen lips the first week. Fever went down after first week. Second week I?ve been dizzy. No appetite. Face tingling and numbness. Headache. I was Covid tested which was negative. Primary doctor has told me it?s neuralgia. Still have dizziness and on and off numbness in back of head and jawline. Sometimes my tongue going numb. An hour or two later my cheek will go numb. Very strange and very annoying. I?m still fatigued with no appetite.  Really hoping it starts to get better soon.
Patient was suppose to receive 2nd dose of Pfizer series, but had received Moderna.
Vaccine administration error. Vaccine was not diluted with sodium chloride and was given to patient undiluted. 0.3ml of undiluted vaccine given to patient. I attempted to call patient to update about event and left a voicemail.  I will continue to contact for update.
Elevated blood pressure readings (158-165/90-95) noted at routine annual physical exam approximately 48 hours after receiving COVID booster. My BP usually runs approximately 105-110/70-76. BP was monitored for 2 hours in physician office. When it did not come down, FNP prescribed valsartan. I monitored BP while awaiting availability of valsartan. BP gradually began to come down and normalized within 8-10 days. I never had to take the valsartan.  Only other symptoms with this booster were (1) fever of 103 F that started about 14 hours after booster and lasted approximately 12 hours and (2) sore arm at injection site and under arm
1/2/08 - red vaccine 1/4/08 - painful left shoulder.  Swelling noted at injection site extending to left breast.
extreme fatigue; inchoherence DSU; Initial information was received on 09-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer or other non-professional (patient).  This case involves a female patient (age unspecified) who had reaction with yellow fever shot and experienced extreme fatigue (fatigue) and inchoherence DSU (incoherent), after she received YELLOW FEVER VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor. Past medical treatment, vaccination, family history and concomitant medication were not provided.  On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, the patient developed a non-serious extreme fatigue (fatigue) and inchoherence DSU (incoherent) (unknown latency) following the administration of YELLOW FEVER VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   At the time of reporting patient was wanted to known if it was safe to for her to take corona virus disease (COVID)-19 vaccine [PFIZER-BIONTECH COVID-19 VACCINE].  It was unknown if there were lab data/results available.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was reported as unknown for the reported events.
This case was reported by a physician and described the occurrence of an injection site reaction in a 2 month old patient who eceived DTaP , hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix). On 30JULY2004, the patient received the first dose of Pediarix in the left leg. On 30JULY2004, the patient also received injections of Hib conjugate vaccine and 7 valent pneumococcal conjugate vaccine which were administered in different limb from the Pediarix injections. Immediately after the administraton of Pediarix on 30JULY2004, the patient experienced an injection site reaction on the left leg characterized as a rash with a red spot and painful. At an unspecified time following the administration of Pediarix, on 30JULY2004, the patient also experienced fussiness. The patient was seen by the reporting physician. The injection site reaction improved and the outcome of the fussiness is unknown. The reporting physician considered the events to possibly be related to vaccination with Pediarix.
Muscle soreness; Bleeding; Cauterization on the nose; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Bleeding nose), CAUTERY TO NOSE (Cauterization on the nose), MYALGIA (Muscle soreness) and in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse drug reaction (No recorded medical history).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced HAEMORRHAGE (Bleeding) and CAUTERY TO NOSE (Cauterization on the nose). On an unknown date, the patient experienced MYALGIA (Muscle soreness) and ARTHRALGIA (Soreness on the legs and knees). At the time of the report, HAEMORRHAGE (Bleeding), CAUTERY TO NOSE (Cauterization on the nose), MYALGIA (Muscle soreness) and ARTHRALGIA (Soreness on the legs and knees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment for the event included vaseline saline spray.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Throat had sensation of closing up and sore arm yesterday evening. Took Benadryl. Today muscle and body aches, low grade 99.9 fever, dizziness.
I had extremely debilitating generalized pain throughout my entire body.; pain was constant in my right arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old male patient received bnt162b2 (BNT162B2), on 12Aug2021 at 11:00 as dose 2, single (Batch/Lot number: unknown) at the age of 29 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing); "hypertension" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: bnt162b2 (DOSE 1, SINGLE , Anatomical location: Arm Left, Vaccine Administration Time: 11:00 am), administration date: 15Jul2021, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset Aug2021, outcome "recovering", described as "I had extremely debilitating generalized pain throughout my entire body."; PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "not recovered", described as "pain was constant in my right arm". The events "i had extremely debilitating generalized pain throughout my entire body." and "pain was constant in my right arm" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain, pain in extremity.  Additional information: Patient was forced by his command staff to take the second vaccine shot or be fired. Within one week of receiving the second vaccine, he had extremely debilitating generalized pain throughout his entire body. The pain was worse at night after working throughout the day pain was constant in his right arm. He would have to take 4 Ibuprofen every night to make the pain go away. After a month the pain in the rest of his body dissipated but the pain in his right arm was still present to this day. He had seen an orthopedic doctor, who believed the pain was not related to any muscular skeletal injuries. He consulted his primary care provider about seeing a rheumatologist, she recommended him to make this report of an adverse reaction first. Patient had no known allergies.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Information has been received from a physician concerning a 14 year old female patient who on 23-JUN-2008 was vaccinated with 0.5ml the first dose of GARDASIL (lot # 659180/17580).  In June 2008, the patient experienced seizure like symptoms such as shaking and then fainted after receiving her first dose of GARDASIL as well as a few other injections.  Other vaccines that the patient received at the time of visit were unknown.  The patient recovered a few minutes after fainting.  The patient sought medical attention.  The physician reported on 23-JUN-2008 the patient received the first dose of GARDASIL (Lot Number 1758U; expiration date June 2010).  Within two to three seconds, the patient's whole body started shaking for five seconds.  The patient then passed out for five seconds and was then lethargic.  The patient experienced a tonic-clonic seizure.  The patient was postictal for twenty minutes.  The patient lay down for fifteen minutes and then sat up for another twenty minutes.  The patient got up fine and then left the office.  No labs or diagnostic tests were performed.  No treatment was given.  Upon internal review, tonic-clonic seizures were determined to be an other important medical event.  This is one of several reports from the same source.  Additional information has been requested.
Patient reports hives on injected arm tenderness in the area and a linear redness on inside of arm but reports no redness at sites of injections. Patient reported this to me approximately 2 days after receiving vaccinations. Patient stated taking BENADRYL which I agreed that she can continue to take to control the hives after consulting immunize.org and reviewing package insert with her on PPSV23 going over reported side effects of medication. Patient received 2 vaccinations in same arm greater than 1 inch apart PPSV23 and HD FLUZONE.
Began with erythema and induration of left leg on 4/20/16 and worsening on 4-21-16.
Information has been received from a physician and a nurse concerning a 24 month old male child who on 10-SEP-2007 was vaccinated IM with a dose of GARDASIL 655849/0263U. Concomitant therapy included HAVRIX. The physician and the nurse reported that the patient was supposed to receive HAVRIX but was given GARDASIL by accident. The nurse who administered the vaccine reported that the child received GARDASIL and received HAVRIX afterwards. The patient also experienced a slight fever lasted until 11-SEP-2007. Unspecified medical attention was sought for the patient. The outcome was unknown. Additional information has been requested.
Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss); Could barely walk; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss)) and GAIT DISTURBANCE (Could barely walk) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O11L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced GAIT DISTURBANCE (Could barely walk). On an unknown date, the patient experienced COVID-19 (Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss)). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19 positive  after first dose of vaccine (fever,chills,coughing,joint pain,diarrhea,sluggishness,loss of appetite,weightloss)) and GAIT DISTURBANCE (Could barely walk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medications included ibuprofen and acetaminophen to relieve side effects.